This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Rectum/anal canal icd-9
CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Rectum/anal canal icd-9
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Rectum/anal canal icd-9
- Benign neoplasm: Rectum, anus and anal canal
- Benign neoplasm: Rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 362 | 175 | 187 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | 47.97 | 44.33 | 51.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 341
- Matched controls
- 3414
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
21140
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Rectum
+∞
212.3
181
*
2114X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Rectum and anal canal[NEOPLASMA BENIGNUM ALIUD RECTI ET CANALIS ANALIS]
+∞
62.4
58
*
2114C
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA TUBULARE RECTI ET CANALIS ANALIS]
+∞
53.5
50
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
421.7
38.8
38
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
36.1
34
*
2114A
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA VILLOSUM RECTI ET CANALIS ANALIS]
+∞
36.1
34
*
6459
FHL
Other measure in this category
187.9
33.3
34
*
2114B
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA TUBULOVILLOSUM RECTI ET CANALIS ANALIS]
+∞
29.6
28
*
116
Kela drug reimbursment
Prostate cancer
+∞
26.4
25
*
1471
FHL
Rectoscopy and polyp removal
234.1
21.8
22
*
45599
ICD-8 Finland
Haemorrhoids
8.3
21.1
48
66
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
222.8
20.8
21
*
1470
FHL
Rectoscopy
35.0
20.5
26
8
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.9
18
*
6449
FHL
Other measure in this category
+∞
18.9
18
*
130
Kela drug reimbursment
Malignant tumour
+∞
16.8
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
UJF32
NOMESCO Finland
Coloscopy
3.1
16.5
112
467
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
15.7
15
*
56500
ICD-8 Finland
Anal fissure and fistula, Anal fissure
12.6
15.3
27
23
H02AB02
ATC
dexamethasone; systemic
14.9
15.3
25
18
6453
FHL
Radical surgery of hemorrhoids
9.3
13.2
27
31
5690A
ICD-9 Finland
Other disorders of intestine, Anal and rectal polyp
52.0
12.9
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
12.9
58
176
L02BB03
ATC
bicalutamide; oral
+∞
12.6
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.1
12.0
29
44
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
6.2
11.0
29
50
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.5
10
*
1491
FHL
Sigmoideoscopy and polyp removal
+∞
10.5
10
*
6451
FHL
Dilatation
12.7
10.0
17
14
6434
FHL
Anterior resection
102.6
9.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
102.6
9.5
10
*
L02BG04
ATC
letrozole; oral
37.7
9.1
11
*
1370
FHL
Colonoscopy, whole colon
19.2
9.0
13
7
HAC20
NOMESCO Finland
Total mastectomy
92.1
8.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
8.4
8
*
6431
FHL
Removal of local change, coagulation or cryotherapy in the laparatomy pathway
+∞
8.4
8
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
8.4
8
*
1380
FHL
Colonoscopy, left side
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
23040
ICD-8 Finland
Neoplasm of unspecified nature of digestive organs, Rectum
+∞
8.4
8
*
A04AA01
ATC
ondansetron; systemic, rectal
7.7
7.8
17
23
1490
FHL
Sigmoideoscopy (fiberscope)
18.9
7.6
11
6
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.9
7.6
30
82
21136
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Coli sigmoidei
81.7
7.4
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.7
7.3
14
15
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
7.3
7
*
L02BA01
ATC
tamoxifen; oral
+∞
7.3
7
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
7.1
34
109
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.0
6.7
14
18
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.5
107
652
N02AX02
ATC
tramadol; systemic, rectal
1.9
6.5
132
863
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
71.0
6.4
7
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
71.0
6.4
7
*
A03CA02
ATC
clidinium and psycholeptics; oral
3.1
6.4
33
112
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.3
6
*
ZXC96
NOMESCO Finland
Robot assisted procedure
27.2
6.2
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
135
2.94
7.80
3.5
1.3
9.4
5.0
ug/l
0.43
22
105
30
102
3.11
7.14
2.6
1.5
—
—
—
0
0
30
112
2.83
6.08
2.7
1.5
—
—
—
0
0
79
482
1.82
4.87
2.7
2.0
—
—
—
0
0
132
937
1.64
4.69
5.0
3.6
—
—
—
0
0
152
1126
1.60
4.50
6.1
3.4
10.0
12.2
umol/l
3.56
141
1030
10
24
4.25
3.90
1.1
1.4
—
—
—
0
0
54
343
1.67
2.86
3.1
2.2
0.8
0.8
mmol/l
0.20
48
310
9
23
3.98
2.79
1.2
1.1
—
—
—
0
0
99
731
1.49
2.74
2.9
2.1
51.6
57.5
u/l
1.58
94
658
9
24
3.81
2.68
1.2
1.1
—
—
—
0
0
9
24
3.81
2.68
1.2
1.1
—
—
—
0
0
9
24
3.81
2.68
1.2
1.1
—
—
—
0
0
9
24
3.81
2.68
1.2
1.1
—
—
—
0
0
8
20
4.06
2.58
1.4
1.1
—
—
—
0
0
50
321
1.65
2.55
4.9
5.1
35.0
33.5
%
0.57
28
199
30
168
1.86
2.44
1.8
1.7
—
—
—
0
0
10
34
2.99
2.43
1.1
1.3
—
—
—
0
0
12
46
2.66
2.38
1.2
1.2
—
—
—
0
0
7
18
3.94
2.26
1.3
1.0
—
—
—
0
0
11
42
2.67
2.20
1.3
1.2
—
—
—
0
0
8
24
3.38
2.19
1.3
1.1
—
—
—
0
0
78
576
1.45
2.13
2.9
2.4
13171.5
10475.1
umol/l
0.11
66
471
197
1702
1.34
2.06
8.9
4.7
77.9
78.1
u/l
0.02
178
1532
147
1221
1.34
1.98
9.1
5.0
1.2
1.2
mmol/l
0.09
126
1024
11
46
2.43
1.86
1.3
1.1
—
—
—
0
0
117
949
1.34
1.82
3.4
3.1
2051.1
2077.0
ng/l
0.02
97
804
47
324
1.52
1.81
3.3
2.4
23.8
21.5
%
0.47
40
284
8
29
2.80
1.80
1.0
1.3
—
—
—
0
0
55
394
1.47
1.76
3.0
2.2
12.9
12.1
umol/l
0.37
50
355
119
976
1.33
1.70
2.4
2.3
—
—
—
0
0
33
214
1.60
1.66
1.6
1.4
66.3
66.5
g/l
0.08
27
182
165
1421
1.30
1.64
6.1
4.0
7.1
6.9
mmol/l
0.47
159
1314
88
695
1.35
1.62
2.4
2.2
2.7
3.1
mg/l
1.14
61
573
5
14
3.60
1.62
1.0
1.0
—
—
—
0
0
6
20
3.03
1.58
1.0
1.5
—
—
—
0
0
131
1104
1.29
1.52
6.9
4.7
1.2
1.2
mmol/l
0.09
115
953
124
1038
1.29
1.51
5.3
3.1
35.0
34.7
g/l
0.30
110
944
7
28
2.53
1.45
1.1
1.1
—
—
—
0
0
23
141
1.67
1.45
6.1
2.8
25.0
25.7
mmol/l
0.68
23
136
12
59
2.07
1.45
2.3
1.4
—
—
—
0
0
6
22
2.75
1.44
1.2
1.1
—
—
—
0
0
142
1217
1.27
1.42
3.5
2.9
42.0
48.7
u/l
0.81
127
1094
136
1164
1.27
1.37
8.5
5.1
4.5
4.6
e9/l
0.15
119
994
58
442
1.37
1.34
2.2
1.8
—
—
—
0
0
181
1612
1.24
1.27
6.1
5.1
193.8
3728.2
e6/l
—
6
28
111
938
1.26
1.23
3.7
2.7
175.8
130.6
ug/l
1.08
90
838
55
424
1.35
1.19
19.8
27.9
1.6
1.4
inr
0.61
19
54
100
848
1.25
1.06
4.3
3.1
—
—
—
0
0
7
33
2.14
1.06
1.3
1.1
—
—
—
0
0
42
317
1.37
1.05
1.2
1.3
3.0
11.4
u/ml
1.29
14
102
5
22
2.29
1.03
2.2
1.4
—
—
—
0
0
5
22
2.29
1.03
1.6
1.1
—
—
—
0
0
95
810
1.23
0.96
2.3
2.1
187.1
204.5
u/l
0.11
88
749
24
167
1.47
0.94
1.7
1.7
—
—
—
0
0
6
27
2.24
0.94
1.3
1.5
112.4
74.8
pmol/l
—
6
27
8
44
1.83
0.86
1.4
1.3
—
—
—
0
0
12
72
1.69
0.86
1.3
1.3
—
—
—
0
0
217
2020
1.18
0.83
22.2
14.2
70.6
69.0
ml/min/173m2
0.56
190
1585
13
82
1.61
0.79
1.0
1.0
—
—
—
0
0
94
818
1.20
0.78
3.5
2.0
2.4
2.4
mmol/l
0.01
76
646
15
99
1.54
0.76
11.1
4.4
24.4
25.3
mmol/l
0.46
15
93
12
75
1.62
0.75
2.5
1.4
—
1.4
—
0
8
23
167
1.40
0.75
2.8
2.3
69.0
55.0
ml/min/173m2
—
10
62
5
24
2.10
0.74
1.0
1.0
—
—
—
0
0
9
55
1.65
0.74
1.7
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
76
1.60
0.72
4.5
2.4
0.4
0.4
u/ml
—
7
37
110
978
1.18
0.71
2.5
2.2
81.4
79.7
nmol/l
0.24
96
827
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
5
27
1.86
0.68
1.2
2.1
—
2.5
—
0
8
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
59
499
1.22
0.66
1.7
1.6
0.9
1.4
mg/l
1.64
48
384
182
1693
1.15
0.64
4.6
4.1
16.6
14.6
mm/h
0.71
157
1510
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
8
49
1.65
0.62
1.9
1.3
—
—
—
0
0
36
291
1.26
0.60
5.3
5.2
1.7
1.9
mmol/l
0.09
30
222
16
116
1.40
0.55
2.1
1.6
1.7
1.6
g/l
—
10
103
76
676
1.16
0.50
4.1
3.0
0.5
0.6
e6/l
0.23
57
522
77
692
1.14
0.44
1.5
1.6
23.4
20.8
nmol/l
0.51
58
578
31
259
1.21
0.42
5.6
3.1
5.7
5.9
kpa
0.68
31
249
78
705
1.13
0.41
6.9
4.1
2.8
2.5
ug/l
0.17
69
610
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
8
61
1.32
0.39
1.1
1.3
—
—
—
0
0
14
106
1.33
0.39
1.1
1.2
9.1
10.6
g/l
—
8
85
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
5
35
1.43
0.39
1.2
1.3
—
—
—
0
0
15
115
1.32
0.39
1.1
1.3
3.5
3.8
g/l
—
7
79
15
115
1.32
0.39
1.1
1.3
7.7
7.8
g/l
—
7
82
15
115
1.32
0.39
1.1
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
7.1
—
0
14
178
1692
1.10
0.38
4.0
3.9
14.9
15.1
pmol/l
0.48
152
1486
62
556
1.14
0.37
4.6
4.3
280.6
170.4
ng/l
0.28
54
485
71
644
1.13
0.36
1.8
1.8
1042.2
1119.8
nmol/l
0.29
41
469
17
136
1.26
0.34
2.9
2.2
1.1
1.1
%
0.13
17
136
39
341
1.16
0.34
1.4
1.3
14.1
31.5
iu/ml
—
6
112
56
506
1.13
0.31
2.8
2.3
2.5
2.5
mmol/l
1.09
48
423
7
55
1.28
0.30
2.4
1.5
—
—
—
0
0
206
1988
1.08
0.29
4.7
4.3
1.2
1.2
mmol/l
0.13
175
1719
22
187
1.19
0.27
2.7
2.0
104.8
30.4
u/l
0.44
17
144
8
66
1.22
0.27
1.1
1.2
—
—
—
0
0
8
66
1.22
0.27
1.1
1.2
—
—
—
0
0
50
546
0.90
0.25
1.8
1.6
1.2
1.3
mmol/l
0.63
40
437
25
217
1.16
0.25
3.2
2.7
4.3
4.3
kpa
0.05
25
206
118
1124
1.07
0.23
5.2
4.1
0.0
0.0
estimate
0.00
21
193
59
546
1.10
0.23
6.0
3.8
21.1
25.4
%
0.88
27
288
5
40
1.25
0.22
1.0
1.3
3.9
4.1
mmol/l
—
5
35
120
1146
1.07
0.22
5.2
4.2
0.0
0.0
estimate
0.00
19
186
36
325
1.12
0.21
9.5
8.5
—
—
—
0
0
5
42
1.19
0.21
1.6
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
21.4
—
0
5
67
627
1.08
0.20
5.4
4.3
0.0
0.0
estimate
0.00
17
181
13
108
1.21
0.20
1.0
1.3
3.2
3.2
g/l
—
7
80
6
49
1.23
0.20
1.8
1.1
—
—
—
0
0
227
2221
1.06
0.18
22.6
15.1
26.7
25.0
mg/l
0.34
197
1766
66
622
1.07
0.17
1.6
1.7
443.0
12422811.1
pmol/l
0.50
50
483
31
282
1.11
0.17
2.8
3.6
274.8
293.2
ng/l
0.10
31
261
37
401
0.91
0.17
1.2
1.2
0.6
1.3
u/ml
—
9
92
28
308
0.90
0.17
1.6
1.8
—
—
—
0
0
117
1127
1.06
0.16
6.8
5.6
0.0
0.0
estimate
0.00
21
186
214
2094
1.05
0.16
5.1
4.8
4.5
4.4
mmol/l
0.16
186
1851
29
264
1.11
0.16
4.4
3.5
—
—
—
0
0
6
77
0.77
0.15
2.3
1.6
—
—
—
0
0
51
542
0.93
0.15
5.2
4.5
1.0
1.0
kg/l
0.88
12
94
9
79
1.14
0.15
2.1
3.1
—
—
—
0
0
211
2066
1.05
0.15
5.2
4.8
1.5
1.5
mmol/l
0.39
181
1811
24
217
1.11
0.15
5.2
3.5
138.4
87.7
ng/l
1.05
17
190
42
392
1.08
0.14
2.6
2.7
1.2
1.5
e6/l
0.40
22
224
40
373
1.08
0.14
2.7
3.0
2.0
2.9
e6/l
0.51
20
205
24
219
1.10
0.13
1.5
1.4
—
—
—
0
0
213
2093
1.04
0.12
7.6
6.7
41.7
41.6
mmol/mol
0.04
183
1872
192
1886
1.04
0.10
18.0
16.9
37.1
38.1
%
0.50
108
1101
220
2167
1.04
0.10
5.5
5.4
2.6
2.5
mmol/l
0.17
190
1908
234
2309
1.04
0.09
13.2
8.8
23.8
22.8
u/l
0.21
217
2162
10
87
1.15
0.09
1.3
1.3
—
—
—
0
0
39
370
1.06
0.09
3.8
2.7
0.9
0.9
ug/l
0.03
22
267
5
61
0.82
0.08
1.0
1.7
—
—
—
0
0
209
2065
1.03
0.07
5.3
4.8
2.0
2.0
mu/l
0.33
179
1810
13
118
1.10
0.07
7.0
6.2
24.9
25.0
mmol/l
0.07
13
105
217
2191
0.97
0.07
6.0
5.0
6.1
6.2
mmol/l
0.28
185
1920
119
1167
1.03
0.07
2.3
2.1
93.1
93.5
pmol/l
0.02
67
578
113
1111
1.02
0.05
5.0
4.2
32.3
70.7
ng/l
0.74
89
852
30
311
0.96
0.04
1.6
1.8
—
—
—
0
0
90
887
1.02
0.03
5.6
4.3
—
—
—
0
0
242
2409
1.01
0.01
31.5
21.8
129.2
131.6
g/l
1.70
236
2332
237
2366
1.00
0.00
25.8
18.7
139.1
139.7
mmol/l
2.13
231
2269
21
208
1.01
0.00
1.1
1.3
—
—
—
0
0
15
149
1.01
0.00
2.1
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
237
2367
1.00
0.00
26.2
18.8
4.0
4.0
mmol/l
0.27
230
2269
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
16.9
—
0
7
5
53
0.94
0.00
1.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9_EXALLC – Benign neoplasm: Rectum/anal canal icd-9
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).